Gautam Samir C, Brooks Charles H, Balogun Rasheed A, Xin Wenjun, Ma Jennie Z, Abdel-Rahman Emaad M
Nephron. 2015;131(3):185-90. doi: 10.1159/000441607. Epub 2015 Nov 3.
Acute kidney injury (AKI) is a frequent complication of hospitalized patients and is associated with poor outcomes. Hospitalized patients with AKI may need prolonged dialysis, necessitating post-hospitalization dialysis (PHD-AKI). Scarce information is available to stratify the risks and predict outcomes. This study aims to assess outcomes and identify predictors of outcomes of PHD-AKI within 90 days.
All adult AKI patients initiating hemodialysis (HD) at the University of Virginia (UVA) between June 1, 2012, and September 30, 2013 were retrospectively studied. PHD-AKI patients continued treatment at a specifically designated unit. They were followed until an outcome (end-stage renal disease [ESRD], death or dialysis-independence) was achieved.
During the study period, 108 patients required outpatient dialysis out of 365 AKI patients initiating in-patient HD at UVA. An additional 11 patients who developed dialysis-requiring AKI at referring hospitals but underwent HD at our unit were included for a total of 119 patients studied. ESRD was declared in 48.7%, while 9.2% expired and 42.0% achieved dialysis independence. Congestive heart failure, baseline renal function and a prior episode of AKI within the preceding 6 months were statistically significant predictors of renal outcomes.
Dialysis independence of PHD-AKI patients is not uncommon. Certain clinical parameters may help predict renal outcome. Identifying predictors of renal recovery will guide further interventions, especially with the Centers for Medicare and Medicaid Services soon to allow AKI patients to be dialyzed at outpatient ESRD facilities. Ongoing biomarkers research may add further knowledge for optimum diagnosis and prognosis of AKI.
急性肾损伤(AKI)是住院患者常见的并发症,且与不良预后相关。患有AKI的住院患者可能需要长期透析,因此需要院后透析(PHD-AKI)。目前关于分层风险和预测预后的信息较少。本研究旨在评估90天内PHD-AKI的预后并确定预后的预测因素。
对2012年6月1日至2013年9月30日在弗吉尼亚大学(UVA)开始进行血液透析(HD)的所有成年AKI患者进行回顾性研究。PHD-AKI患者在专门指定的科室继续接受治疗。对他们进行随访,直至达到某种结局(终末期肾病[ESRD]、死亡或无需透析)。
在研究期间,UVA开始接受住院HD的365例AKI患者中有108例需要门诊透析。另外11例在转诊医院发生需要透析的AKI但在我们科室接受HD的患者也被纳入研究,共计119例患者。48.7%的患者被诊断为ESRD,9.2%的患者死亡,42.0%的患者实现了无需透析。充血性心力衰竭、基线肾功能以及前6个月内既往的AKI发作是肾脏预后的统计学显著预测因素。
PHD-AKI患者实现无需透析并不罕见。某些临床参数可能有助于预测肾脏预后。确定肾脏恢复的预测因素将指导进一步的干预措施,特别是随着医疗保险和医疗补助服务中心即将允许AKI患者在门诊ESRD设施进行透析。正在进行的生物标志物研究可能会为AKI的最佳诊断和预后增加更多知识。